The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma
Abstract
HLA haplotypes of 27 patients with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy (HAM) and 12 patients with adult T-cell leukemia/lymphoma (ATLL) were examined by analyzing HLA types of the patients and their family members. Either A11Bw54Cw1DR4DQw3, A24Bw54Cw1DR4DQ-, A24B7Cw7DR1DQw1, or A24Bw52Cw-DR2DQw1 and the related haplotypes were found in 70% of cases with HAM. None of these "HAM-associated" haplotypes was found in patients with ATLL. HLA haplotypes made up of HLA components of A26Bw62Cw3DR5DQw3 and one particular haplotype of Aw33B44Cw-DRw6DQw1 were associated with the ATLL haplotypes. These "ATLL-associated" haplotypes were also found in the patients with HAM who had no previous history of blood transfusion. The in vitro cultures of peripheral blood lymphocytes with HTLV-I virion antigens revealed that the response with HAM peripheral blood lymphocytes was remarkably higher than that with ATLL peripheral blood lymphocytes. Based on this HTLV-I-specific immune responsiveness, we can segregate the high responders in HAM (14 of 16 cases) and the low responders in ATLL (6 of 7 cases). The existence of high and low responders was also confirmed by the normal healthy individuals, whose responses were segregated with HAM-associated and ATLL-associated haplotypes. These results suggested that two ethnic groups in southern Kyushu may get the two different diseases, HAM and ATLL, because of their different immunogenetic backgrounds. The high immune response to HTLV-I seems to be an important genetic factor in the development of HAM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Gessain, A., Vernant, J. C., Maurs, L., Barin, F., Gout, O., Calender, A., & De Thé, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92734-5 · Cited by 2,843
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,404
Self-citationYoshida, M., Miyoshi, I., & Hinuma, Y. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2031 · Cited by 2,169
Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., & Hinuma, Y. (1981) · Nature · doi:10.1038/294770a0 · Cited by 1,402
Kalyanaraman, V. S., Sarngadharan, M. G., Robert-Guroff, M., Miyoshi, I., Blayney, D., Golde, D., & Gallo, R. C. (1982) · Science · doi:10.1126/science.6981847 · Cited by 1,196
Role of MHC Gene Products in Immune Regulation
Benacerraf, B. (1981) · Science · doi:10.1126/science.6165083 · Cited by 696
Osame, M., Matsumoto, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Tara, M., & Igata, A. (1987) · Annals of Neurology · doi:10.1002/ana.410210203 · Cited by 625
Self-citationISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY
Hirose, S., Uemura, Y., Fujishita, M., Kitagawa, T., Yamashita, M., Imamura, J., Ohtsuki, Y., Taguchi, H., & Miyoshi, I. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90081-4 · Cited by 556
Brahams, D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90821-x · Cited by 533
Mother-to-child transmission of human T-cell leukemia virus type-I.
Hino, S., Yamaguchi, T., Katamine, S., Sugiyama, H., Amagasaki, T., Kinoshita, K.-I., Yoshida, Y., Doi, H., Tsuji, Y., & Miyamoto, T. (1985) · PubMed · Cited by 345
HTLV-I AND HTLV-III ANTIBODIES AND TROPICAL SPASTIC PARAPARESIS
Rodgers-Johnson, P., Carleton Gajdusek, D., Morgan, O., Zaninovic, V., Sarin, P., & Graham, D. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90778-0 · Cited by 270
Feldman, W. H. (1964) · Tubercle · doi:10.1016/s0041-3879(64)80058-1 · Cited by 266
Vernant, J. C., Maurs, L., Gessain, A., Barin, F., Gout, O., Delaporte, J. M., Sanhadji, K., Buisson, G., & De‐Thé, G. (1987) · Annals of Neurology · doi:10.1002/ana.410210204 · Cited by 265
Non-treatment of defective newborn babies.
SILVERMAN, W. A. (1980) · PubMed · Cited by 227
SPASTIC PARAPARESIS: A POSSIBLE SEXUALLY TRANSMITTED VIRAL MYELONEUROPATHY
ZANINOVIC, V (1986) · The Lancet · doi:10.1016/s0140-6736(86)90217-5 · Cited by 221
BLOOD TRANSFUSION AND HTLV-I ASSOCIATED MYELOPATHY
Osame, M., Izumo, S., Igata, A., Matsumoto, M., Matsumoto, T., Sonoda, S., Tara, M., & Shibata, Y. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91636-3 · Cited by 205
Self-citationCj, D. (1964) · PubMed · Cited by 176
NECROPSY FINDINGS IN HTLV-I ASSOCIATED MYELOPATHY
Akizuki, S., Nakazato, O., Higuchi, Y., Tanabe, K., Setoguchi, M., Yoshida, S., Miyazaki, Y., Yamamoto, S., Sudou, S., Sannomiya, K., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91984-2 · Cited by 165
Yoshida, M., Osame, M., Usuku, K., Matsumoto, M., & Igata, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90506-x · Cited by 120
Self-citationBhate, S. R. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90717-7 · Cited by 115
Estimation of Rate of Incidence of ATL Among ATLV (HTLV-I) Carriers in Kyushu, Japan
TAJIMA, K., & Kuroishi, M. (1985) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a039062 · Cited by 113
Newton, M. R., Miller, D. H., Rudge, P., Cruickshank, K. J., Dalgleish, A. G., Clayden, S. A., & MOSELEY, I. F. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90120-6 · Cited by 109
HTLV-I AND TROPICAL SPASTIC PARAPARESIS
Bartholomew, C., Cleghorn, F. R., Charles, W., Ratan, P., Roberts, L., Maharaj, K., Jankey, N., Daisley, H., Hanchard, B., & Blattner, W. A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91626-0 · Cited by 107
HTLV-I AND TROPICAL SPASTIC PARAPARESIS IN AFRICA
Gessain, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90218-7 · Cited by 90
Retrovirus-Associated Myelopathies
Román, G. C. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520180073022 · Cited by 69
Rowlands, D. F. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92328-x · Cited by 63
Myelopathies and retroviral infections
Johnson, R. T., & McArthur, J. C. (1987) · Annals of Neurology · doi:10.1002/ana.410210202 · Cited by 61
Clinical Electrophysiologic Studies of HTLV-I-Associated Myelopathy
Arimura, K., Rosales, R. K., Osame, M., & Igata, A. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520180033012 · Cited by 61
Self-citationPatterns of Persistent Viral Infections
Haywood, A. M. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610093151506 · Cited by 50
Cited by
Global epidemiology of HTLV-I infection and associated diseases
Proietti, F. A., Carneiro-Proietti, A. B. F., Catalan-Soares, B. C., & Murphy, E. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208968 · Cited by 1,008
Nagai, M., Usuku, K., Matsumoto, W., Kodama, D., Takenouchi, N., Moritoyo, T., Hashiguchi, S., Ichinose, M., Bangham, C. R., Izumo, S., et al. (1998) · Journal of Neurovirology · doi:10.3109/13550289809114225 · Cited by 694
Self-citationJacobson, S., Shida, H., McFarlin, D. E., Fauci, A. S., & Koenig, S. (1990) · Nature · doi:10.1038/348245a0 · Cited by 613
Jeffery, K. J. M., Usuku, K., Hall, S. E., Matsumoto, W., Taylor, G. P., Procter, J., Bunce, M., Ogg, G. S., Welsh, K. I., Weber, J. N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3848 · Cited by 419
Self-citationPathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection
Flier, J. S., Underhill, L. H., Hollsberg, P., & Hafler, D. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304223281608 · Cited by 318
Metadata
- Authors
- Usuku, K., Sonoda, S., Osame, M., Yashiki, S., Takahashi, K., Matsumoto, M., Sawada, T., Tsuji, K., Tara, M., & Igata, A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1988
- Volume
- 23
- Issue
- S1
- Pages
- S143-S150
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2045033555
- Cited by
- 284
- References
- 31
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.